SunnyBay BioTech, Inc.
Fremont, US · Founded 2022 · Delaware corporation · 1 known investors
Founders & leadership
FW
Feng Wang-JohanningNamed on SEC filing
GJ
Gary JohanningNamed on SEC filing
Board
XC
Xiangmin CuiBoard director
PC
Investors · 1
Reported raises · per SEC filings
Form D private placements$2.2M disclosed across 1 round · 2023
▶$2.2MraisedJan 2023 · 3 investors · BiotechnologyRule 506(b)
▶$2.2MraisedJan 2023 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Feng Wang-JohanningExecutive Officer, Director
- Xiangmin CuiDirector
- Gary JohanningExecutive Officer
- Peter ColabuonoDirector
- Offering amount
- $6M
- Amount sold
- $2.2M
- First sale
- Jan 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are SunnyBay BioTech, Inc.'s investors?
- SunnyBay BioTech, Inc.'s investors include Decheng Capital.
- How much funding has SunnyBay BioTech, Inc. raised?
- SunnyBay BioTech, Inc. has disclosed $2.2M raised across 1 round.
- Where is SunnyBay BioTech, Inc. headquartered?
- SunnyBay BioTech, Inc. is headquartered in Fremont, US.